av/arcadia-biosciences--big.svg

NASDAQ:RKDA

Arcadia Biosciences

  • Stock

USD

Last Close

2.81

30/08 20:00

Market Cap

4.16M

Beta: 0.96

Volume Today

3.58K

Avg: 172.60K

PE Ratio

−0.33

PFCF: −0.20

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
674K
-
437K
35.16%
359K
17.85%
273K
23.96%
240.50K
11.90%
205K
14.76%
987.50K
381.71%
2.80M
183.85%
4.12M
47.07%
3.50M
15.05%
2.26M
35.34%
average payables
178.50K
-
232K
29.97%
1.33M
474.78%
1.32M
0.82%
294K
77.77%
1.51M
412.07%
1.57M
4.18%
2.30M
46.54%
3.87M
68.44%
3.26M
15.81%
1.84M
43.52%
average receivables
1.13M
-
1.22M
8.28%
1.10M
9.65%
660.50K
40.23%
884K
33.84%
701.50K
20.64%
385K
45.12%
1.00M
160.78%
1.39M
38.25%
1.33M
4.29%
900.50K
32.22%
book value per share
-422.91
-
-46.09
89.10%
1.13K
2,544.92%
400.27
64.48%
148.54
62.89%
136.10
8.38%
48.44
64.41%
111.36
129.91%
58.44
47.52%
35.09
39.96%
10.38
70.42%
capex per share
-2.44
-
-3.62
48.00%
-4.23
16.89%
-4.17
1.53%
-1.47
64.82%
-2.66
81.17%
-9.28
249.70%
-9.38
1.01%
-1.89
79.82%
-0.12
93.65%
-0.00
96.63%
capex to depreciation
-0.26
-
-0.41
61.64%
-0.51
24.24%
-0.76
47.95%
-0.28
62.74%
-1.62
473.32%
-7.61
368.99%
-3.53
53.67%
-0.96
72.68%
-0.15
84.40%
-0.01
96.62%
capex to operating cash flow
0.01
-
0.01
2.46%
0.01
0.15%
0.01
35.52%
0.01
58.23%
0.02
224.21%
0.09
368.26%
0.08
10.03%
0.04
49.62%
0.01
86.77%
0.00
93.65%
capex to revenue
-0.02
-
-0.02
37.32%
-0.03
31.58%
-0.07
159.80%
-0.02
72.92%
-0.17
770.25%
-1.26
639.89%
-0.29
77.00%
-0.15
48.90%
-0.01
95.13%
-0.00
87.03%
cash per share
69.32
-
405.16
484.51%
1.41K
247.38%
911.68
35.22%
241.59
73.50%
231.77
4.07%
159.24
31.29%
103.09
35.26%
53.92
47.70%
34.44
36.12%
9.41
72.67%
days of inventory on hand
244.06
-
77.50
68.25%
120.30
55.24%
102.77
14.57%
295.35
187.39%
99.95
66.16%
739.90
640.29%
267.62
63.83%
185.81
30.57%
95.74
48.48%
216.57
126.21%
days payables outstanding
119.32
-
44.60
62.62%
991.47
2,123.19%
90.54
90.87%
472.05
421.39%
1.46K
209.41%
202.92
86.11%
288.19
42.03%
152.49
47.09%
107.28
29.65%
88.60
17.42%
days sales outstanding
57.70
-
74.34
28.84%
53.13
28.54%
61.02
14.87%
111.97
83.48%
41.89
62.59%
187.96
348.76%
63.88
66.02%
73.75
15.46%
47.18
36.03%
35.20
25.40%
debt to assets
1.53
-
0.58
61.90%
0.31
46.89%
0.44
43.80%
0.00
-
0.07
5,594.17%
0.20
187.36%
0.08
62.03%
0.07
7.02%
0.05
26.72%
debt to equity
-0.84
-
-7.68
812.01%
0.57
107.42%
1.13
98.56%
0.00
-
0.29
12,741.10%
0.34
16.08%
0.11
68.59%
0.10
9.48%
0.08
18.22%
dividend yield
0.00
-
earnings yield
-0.06
-
-0.08
38.98%
-0.21
169.38%
-0.48
132.46%
-1.32
175.48%
-1.13
14.76%
-0.83
26.66%
-0.24
71.12%
-0.73
204.81%
-2.40
229.61%
-3.61
50.29%
enterprise value
250.59M
-
236.76M
5.52%
87.77M
62.93%
63.93M
27.16%
2.73M
95.72%
-58.51K
102.14%
28.69M
49,135.55%
20.51M
28.53%
-3.26M
115.89%
-12.13M
272.17%
-1.64M
86.48%
enterprise value over ebitda
-24.64
-
-16.00
35.05%
-5.95
62.81%
-3.56
40.24%
-0.20
94.41%
0.00
101.29%
-1.40
55,011.46%
-0.98
29.89%
0.18
118.02%
0.53
200.82%
0.13
76.16%
ev to operating cash flow
-25.71
-
-16.01
37.73%
-5.81
63.72%
-3.75
35.48%
-0.20
94.78%
0.00
102.19%
-1.67
38,965.19%
-0.68
59.32%
0.13
118.57%
0.87
588.80%
0.11
87.65%
ev to sales
38.68
-
33.91
12.34%
16.21
52.19%
20.05
23.69%
0.68
96.61%
-0.04
105.89%
24.54
61,509.78%
2.55
89.60%
-0.48
118.83%
-1.22
153.45%
-0.31
74.75%
free cash flow per share
-240.71
-
-365.16
51.70%
-427.47
17.07%
-311.70
27.08%
-260.53
16.41%
-147.42
43.42%
-117.40
20.37%
-130.75
11.37%
-50.52
61.36%
-23.44
53.60%
-12.37
47.23%
free cash flow yield
-0.04
-
-0.06
51.70%
-0.18
181.11%
-0.42
140.94%
-1.18
179.63%
-1.16
1.83%
-0.54
53.93%
-1.29
141.24%
-1.21
6.01%
-2.16
78.06%
-3.95
82.75%
graham net net
-562.62
-
-218.20
61.22%
475.21
317.78%
301.30
36.60%
102.05
66.13%
115.02
12.72%
15.29
86.71%
39.49
158.24%
36.10
8.57%
24.81
31.27%
4.85
80.44%
graham number
1.75K
-
681.89
61.08%
3.57K
423.71%
1.79K
50.01%
986.83
44.72%
662.11
32.91%
444.75
32.83%
246.26
44.63%
199.70
18.91%
143.40
28.19%
51.38
64.17%
income quality
0.74
-
0.81
9.18%
0.84
4.36%
0.87
3.29%
0.89
2.30%
1.01
13.73%
0.60
41.10%
5.01
741.88%
1.60
68.03%
0.90
44.16%
1.16
29.81%
intangibles to total assets
0
-
0
0
0
0
0
0
0.02
Infinity%
0.01
32.93%
0.00
87.45%
0.00
43.11%
interest coverage
-16.88
-
-10.87
35.60%
-5.86
46.14%
-14.12
141.10%
-19.16
35.75%
-4.08K
-
-459.40
88.73%
-1.78K
286.65%
-67.14
96.22%
interest debt per share
371.39
-
388.00
4.47%
716.82
84.75%
476.87
33.47%
13.86
97.09%
0.31
97.78%
14.11
4,480.19%
37.75
167.61%
6.23
83.50%
3.85
38.24%
0.81
78.84%
inventory turnover
1.50
-
4.71
214.93%
3.03
35.58%
3.55
17.06%
1.24
65.20%
3.65
195.51%
0.49
86.49%
1.36
176.47%
1.96
44.03%
3.81
94.08%
1.69
55.79%
invested capital
-0.84
-
-7.68
812.01%
0.57
107.42%
1.13
98.56%
0.00
-
0.29
12,741.10%
0.34
16.08%
0.11
68.59%
0.10
9.48%
0.08
18.22%
market cap
238.86M
-
238.86M
0%
86.82M
63.65%
40.82M
52.99%
11.86M
70.95%
11.94M
0.68%
34.87M
192.05%
25.20M
27.74%
22.13M
12.16%
6.50M
70.64%
3.87M
40.41%
net current asset value
-22.27M
-
-8.08M
63.73%
18M
322.80%
17.85M
0.86%
6.48M
63.67%
11.67M
79.94%
4.19M
64.07%
12.90M
207.73%
22.67M
75.71%
17.38M
23.34%
7.97M
54.13%
net debt to ebitda
-1.15
-
0.14
112.28%
-0.06
145.80%
-1.29
1,881.54%
0.66
151.59%
0.52
20.94%
0.30
42.34%
0.23
25.53%
1.38
513.90%
0.82
40.70%
0.43
47.81%
net income per share
-322.62
-
-448.39
38.98%
-503.00
12.18%
-353.85
29.65%
-291.38
17.65%
-143.16
50.87%
-181.50
26.78%
-24.20
86.67%
-30.33
25.30%
-26.05
14.11%
-11.30
56.60%
operating cash flow per share
-238.26
-
-361.54
51.74%
-423.24
17.07%
-307.53
27.34%
-259.07
15.76%
-144.76
44.12%
-108.11
25.32%
-121.37
12.26%
-48.62
59.94%
-23.32
52.04%
-12.36
46.98%
payables turnover
3.06
-
8.18
167.54%
0.37
95.50%
4.03
995.11%
0.77
80.82%
0.25
67.68%
1.80
619.78%
1.27
29.59%
2.39
88.99%
3.40
42.14%
4.12
21.09%
receivables turnover
6.33
-
4.91
22.39%
6.87
39.93%
5.98
12.94%
3.26
45.50%
8.71
167.32%
1.94
77.72%
5.71
194.26%
4.95
13.39%
7.74
56.31%
10.37
34.05%
research and ddevelopement to revenue
1.30
-
1.43
10.53%
1.66
15.49%
2.72
64.09%
1.84
32.30%
4.15
125.32%
6.07
46.47%
0.99
83.68%
0.57
42.11%
0.15
73.58%
0.26
71.69%
return on tangible assets
-1.38
-
-0.74
46.72%
-0.24
67.18%
-0.35
43.42%
-0.95
173.28%
-0.56
40.81%
-0.89
57.97%
-0.13
85.40%
-0.37
187.07%
-0.54
45.52%
-0.71
31.52%
revenue per share
158.39
-
170.71
7.78%
151.66
11.16%
57.48
62.10%
74.69
29.92%
15.55
79.18%
7.35
52.74%
32.27
339.11%
12.74
60.51%
16.61
30.34%
4.31
74.06%
roe
0.76
-
9.73
1,175.34%
-0.45
104.59%
-0.88
98.04%
-1.96
121.90%
-1.05
46.38%
-3.75
256.24%
-0.22
94.20%
-0.52
138.74%
-0.74
43.05%
-1.09
46.68%
roic
4.03
-
-1.22
130.32%
-0.25
79.81%
-0.39
59.64%
-1.79
354.57%
-1.31
26.60%
-1.69
28.66%
-0.49
71.03%
-0.94
92.46%
-0.77
17.84%
-0.99
27.88%
sales general and administrative to revenue
1.23
-
1.45
17.92%
2.05
41.61%
3.84
87.10%
2.65
31.15%
7.93
199.61%
11.61
46.42%
2.05
82.34%
shareholders equity per share
-422.91
-
-46.09
89.10%
1.13K
2,544.92%
400.27
64.48%
148.54
62.89%
136.10
8.38%
48.44
64.41%
111.36
129.91%
58.44
47.52%
35.09
39.96%
10.38
70.42%
stock based compensation to revenue
0.20
-
0.14
29.14%
0.26
83.93%
0.33
29.20%
0.37
10.22%
1.06
189.18%
1.96
84.78%
0.25
87.01%
0.23
10.58%
0.11
51.12%
0.13
21.09%
tangible asset value
-17.30M
-
-1.89M
89.10%
40.23M
2,233.95%
22.20M
44.82%
8.01M
63.93%
12.81M
60.05%
8.33M
35.03%
27.77M
233.58%
30.71M
10.58%
20.86M
32.08%
12.66M
39.29%
tangible book value per share
-422.91
-
-46.09
89.10%
1.13K
2,544.92%
400.27
64.48%
148.54
62.89%
136.10
8.38%
52.34
61.54%
111.55
113.13%
57.73
48.25%
34.80
39.71%
10.24
70.58%
working capital
-4.98M
-
7.43M
249.21%
48.57M
554.01%
49.09M
1.08%
11.52M
76.53%
19.82M
72.04%
22.73M
14.68%
25.38M
11.66%
30.35M
19.57%
21.19M
30.18%
11.38M
46.28%

All numbers in USD (except ratios and percentages)